文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

七问题工具(PRISMA-7)在急诊科预测老年人预后中的验证:一项前瞻性研究

Validation of a seven-question tool (PRISMA-7) in predicting prognosis of older adults in the emergency department: A prospective study.
PubMed 文献 · Am J Emerg Med · 2023-08-24
一句话结论在急诊≥65岁患者中,PRISMA-7预测28天全因死亡的AUC为0.80,与qSOFA无显著差异,但预测ICU转入优于ESI和qSOFA。

本研究为前瞻性多中心观察性研究,纳入三家三级医疗中心8周内急诊就诊的≥65岁连续患者1043例,评估PRISMA-7对28天全因死亡和ICU转入的预测效度。主要终点28天全因死亡采用Cox比例风险回归模型分析,PRISMA-7的AUC为0.80(95%CI 0.76-0.84),ESI为0.73(95%CI 0.68-0.77),qSOFA为0.78(95%CI 0.73-0.83),PRISMA-7与qSOFA的AUC无差异(p=0.374)。次要终点ICU转入采用多变量logistic回归分析,PRISMA-7的AUC为0.78(95%CI 0.75-0.80),ESI为0.62(95%CI 0.59-0.66),qSOFA为0.68(95%CI 0.64-0.72),PRISMA-7与ESI、PRISMA-7与qSOFA、qSOFA与ESI的AUC差异均有统计学意义(p<0.001、p<0.001、p=0.005)。结论提示PRISMA-7改善ICU转入预测,但在全因死亡预测方面无显著差异,PRISMA-7似乎是急诊识别衰弱的可靠有效工具。

要点

  • PRISMA-7预测急诊≥65岁患者28天全因死亡的AUC为0.80(95%CI 0.76-0.84),与qSOFA的0.78(95%CI 0.73-0.83)无显著差异(p=0.374)。
  • PRISMA-7预测ICU转入的AUC为0.78(95%CI 0.75-0.80),优于ESI的0.62(95%CI 0.59-0.66,p<0.001)和qSOFA的0.68(95%CI 0.64-0.72,p<0.001)。
  • qSOFA预测ICU转入的AUC为0.68(95%CI 0.64-0.72),亦优于ESI的0.62(95%CI 0.59-0.66),差异有统计学意义(p=0.005)。
  • 作者认为PRISMA-7似乎是急诊识别衰弱的可靠有效工具,可改善ICU转入预测,但对全因死亡预测与qSOFA无显著差异。

适用人群与场景

  • 三家三级医疗中心(四川大学华西医院、华西医院上锦南府、河南省人民医院)8周期间急诊就诊的年龄≥65岁连续患者1043例。

研究设计与关键结果

  • 研究设计为前瞻性多中心观察性研究,最终研究人群为1043例年龄≥65岁的连续患者。
  • 主要终点28天全因死亡采用Cox比例风险回归模型评估预测效度,PRISMA-7的AUC为0.80(95%CI 0.76-0.84),ESI为0.73(95%CI 0.68-0.77),qSOFA为0.78(95%CI 0.73-0.83)。
  • PRISMA-7与qSOFA预测28天全因死亡的AUC无差异(p=0.374)。
  • 次要终点ICU转入采用多变量logistic回归分析,PRISMA-7的AUC为0.78(95%CI 0.75-0.80),ESI为0.62(95%CI 0.59-0.66),qSOFA为0.68(95%CI 0.64-0.72)。
  • PRISMA-7与ESI预测ICU转入的AUC差异有统计学意义(p<0.001),PRISMA-7与qSOFA差异有统计学意义(p<0.001),qSOFA与ESI差异有统计学意义(p=0.005)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为PRISMA-7改善ICU转入预测,但在全因死亡预测方面与qSOFA无显著差异,PRISMA-7似乎是急诊识别衰弱的可靠有效工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Older patients arrive at the emergency department (ED) with complex medical challenges, and the current ED triage models frequently undertriage the severity of illness in older adults. There is increasing awareness regarding the importance of identifying frailty in older patients in the context of urgent care. Therefore, this study aimed to assess the predictive accuracy of the seven-question tool of the Program on Research for Integrating Services of the Maintenance of Autonomy (PRISMA-7) in the ED for 28-day mortality among older adults.

DESIGN: A prospective polycentric observational study.

SETTING: West China Hospital of Sichuan University, Shangjinnanfu of West China Hospital, and People's Hospital of Henan Province.

PARTICIPANTS: ED patients aged ≥65 years from the three tertiary care centers over an 8-week period.

PRIMARY AND SECONDARY OUTCOMES: The primary outcome, 28-day all-cause mortality, was investigated using a Cox proportional hazards regression model to assess the predictive validity. The secondary endpoints, intensive care unit (ICU) transfer was investigated using multivariable logistic regression, compared with trained study assistants.

RESULTS: The final study population comprised 1043 consecutive patients aged ≥65 years. The area under the receiver operating characteristic (ROC) curve (AUC) for 28-day mortality was 0.80 (95% confidence interval [CI]: 0.76-0.84), 0.73 (95% CI: 0.68-0.77), and 0.78 (95% CI: 0.73-0.83) for PRISMA-7, Emergency Severity Index (ESI), and quick Sepsis Related Organ Failure Assessment (qSOFA), respectively.There was no difference in the AUC between PRISMA-7 and qSOFA(p = 0.374).The AUC for ICU admission was 0.78 (95% CI: 0.75-0.80), 0.62 (95% CI: 0.59-0.66), and 0.68 (95% CI: 0.64-0.72) for PRISMA-7, ESI, and qSOFA, respectively.The AUC for ICU admission between PRISMA-7 and ESI(p<0.001), PRISMA-7 and qSOFA(p<0.001), qSOFA and ESI(p = 0.005) was statistically significant.

CONCLUSION: Our findings reveal that PRISMA-7 improves the prediction of ICU admission, but there is no significant difference when it comes to all-cause mortality. PRISMA-7 appears to be a reliable and valid instrument for identifying frailty in the ED.

TRIAL REGISTRATION NUMBER: ChiCTR2100046545.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Wang GQ, Gao YL, Deng P, et al. Validation of a seven-question tool (PRISMA-7) in predicting prognosis of older adults in the emergency department: A prospective study. Am J Emerg Med. 2023. PMID: 37657142. doi:10.1016/j.ajem.2023.08.030

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。